TIMP1 and diffuse large B-cell lymphoma: Predictive biomarkers of a poor prognosis such as metalloproteinase inhibitor-1 (TIMP-1) in a particular DLBCL subtype were validated in two independent cohorts (n = 180) and compared with the current IPI score classification system.